Acutus Medical Inc. (AFIB)
OTC: AFIB
· Real-Time Price · USD
0.04
-0.00 (-4.76%)
At close: Apr 04, 2025, 3:23 PM
Acutus Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.31M | -5.72M | -362K | -2.06M | -33.77M | -13.24M | -18.35M | -4.28M | 15.11M | -20.43M | 5.72M | -40.02M | -31.26M | -28.51M | -28.73M | -29.18M |
Depreciation & Amortization | 250K | 257K | 256K | 264K | -3.29M | 1.25M | 1.4M | 257K | 1.63M | 1.72M | 1.9M | 1.89M | 1.69M | 1.79M | 1.83M | 1.58M |
Stock-Based Compensation | n/a | 128K | 129K | 202K | -1.88M | 1.28M | 1.74M | 586K | 1.89M | 1.88M | 2.58M | 3.03M | 3.49M | 3.58M | 3.78M | 2.91M |
Other Working Capital | 724K | 6.04M | -684K | n/a | 1.23M | -400K | 3.38M | -622K | 3.14M | -516K | -2.11M | -1.9M | 1.41M | -2.45M | 1.35M | 2.12M |
Other Non-Cash Items | -5.14M | -4.27M | -4M | 87K | 69.75M | -197K | 269K | -13.31M | -35.22M | -3.42M | -34.27M | 12.58M | 2.17M | -1.59M | 86K | -825K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -47.95M | -3.26M | -2.05M | n/a | n/a | n/a | n/a | n/a | 294K | 214K | 385K | 412K |
Change in Working Capital | 2.14M | 5.91M | -2.99M | -2.92M | -880K | 165K | 2.41M | 1.02M | 3.61M | -3.59M | 3.47M | -5.09M | 1.04M | -2.67M | -991K | -1.17M |
Operating Cash Flow | -4.06M | -3.7M | -6.97M | -16.93M | -18.01M | -14.01M | -14.58M | -15.73M | -12.98M | -23.84M | -20.61M | -27.61M | -22.58M | -27.19M | -23.64M | -26.27M |
Capital Expenditures | 36K | -5K | -38K | -105K | 1.18M | -410K | -752K | -25K | -1.51M | -755K | -630K | -1.09M | -3.39M | -746K | -2.15M | -3.69M |
Cash Acquisitions | 5.44M | -10.28M | 2.98M | 7.3M | -1.11M | n/a | -15.89M | 17M | 20M | 2.49M | 50M | n/a | -17.24M | -78.61M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -1.24M | -4.64M | -5.86M | -28.02M | -21.27M | -33.23M | n/a | n/a | -17.24M | -60.89M | 1K | -9.13M |
Sales Maturities Of Investments | n/a | n/a | 1.5M | 1.75M | 12.5M | 22M | 21.75M | 26.5M | 15M | 37.35M | 23.8M | 17.09M | 9.2M | 58.1M | 24M | 25M |
Other Investing Acitivies | n/a | 13.26M | 31K | 7.3M | -1.21M | n/a | 15.89M | n/a | 13.73M | 6.61M | -2.49M | 17.09M | 17.24M | 78.61M | 24M | 15.87M |
Investing Cash Flow | 5.47M | 2.98M | 4.47M | 9.23M | 11.22M | 16.95M | 15.14M | 15.25M | 12.22M | 5.85M | 70.68M | 16M | -11.42M | -3.53M | 21.85M | 12.17M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.06M | 899K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | 275K | -252K | -46K | -217K | -49K | -17K | -45K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -225K | n/a | -2.62M | -42K | -9.72M | -1.68M | 25K | 4K | 1.1M | -1.34M | -11.56M | -42K | -507K | -432K | 229K | -2.38M |
Financial Cash Flow | -225K | n/a | -2.62M | -42K | -495K | -1.94M | -21K | -213K | -15K | -458K | -11.6M | -42K | -514K | 82.23M | 229K | -2.38M |
Net Cash Flow | 1.42M | -732K | -5.13M | -7.74M | -4.92M | 1.06M | 180K | -1.47M | -805K | -18.56M | 38.25M | -11.75M | -34.42M | 51.37M | -1.5M | -16.6M |
Free Cash Flow | -4.02M | -3.7M | -7.01M | -17.03M | -16.84M | -14.42M | -15.33M | -15.75M | -14.49M | -24.59M | -21.24M | -28.7M | -25.97M | -27.93M | -25.79M | -29.97M |